Market Research Report
Single-use Bioprocessing Material Market By Material (Plastic, Silicone, Others), By Application (Media Bags & Containers, Tubes, Filters, Sampling Systems, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
|Single-use Bioprocessing Material Market By Material (Plastic, Silicone, Others), By Application (Media Bags & Containers, Tubes, Filters, Sampling Systems, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030|
Published: March 1, 2022
Allied Market Research
Content info: 180 Pages
Delivery time: 2-3 business days
Single-use bioprocessing system refers to biopharmaceutical manufacturing equipment designed to be used once (or for a single manufacturing campaign) and then discarded. Generally, SUS equipment is composed primarily of plastic components that have been sealed and sterilized using gamma irradiation. The primary benefits of SUS versus classic stainless steel (or glass less frequently used in bioprocessing) is that the equipment comes sterile, allowing avoidance of cleaning, sterilization, and validation of sterilization prior to usage; and avoidance of related complex steam, WFI, and other plumbing installed throughout bioprocessing facilities with large fixed stainless steel components. With SUS equipment essentially plug-and-play, process turnaround and set up of new processing lines are much quicker, avoiding weeks of cleaning/sterilization/validation required with reused stainless steel equipment.
In addition, with much less facility infrastructure required, including no need for a lot of plumbing or an in-house WFI plant, and with bioprocessing suites as simple as empty rooms to be filled with a SUS-assembled process line, the facility footprint can be much smaller, investment & construction costs much lower, and new process lines & facilities come online much faster & simpler versus stainless steel.
The key factors that drive the demand for single-use bioprocessing products include rise in adoption of single use technologies across pharmaceutical manufacturing facilities, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. This has further led to the development of single-use bioprocessing products using advanced materials as shelf-life of SUB products relies upon the stability of plastic ware and its sterility.
The Single-Use Bioprocessing Material market in this report is studied on the basis of material, application, and region. On the basis of material, the market is divided into plastic, silicone, and others. By plastic materials, the market is further divided into polyethylene, polyvinyl chloride, polyamide, polyvinylidene fluoride, and other plastic materials. By application, the market is classified into media bags & containers, tubes, filters, sampling systems, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America dominated the market in 2020, owing to increased demand for biopharmaceuticals owing to the rise in geriatric population. The advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the North America single-use bioprocessing material market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to presence of favorable government support, rise in private investments, growth in geriatric population, surge in trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries.
The major players operating in the global Single-use bioprocessing material market are Arkema S.A., BASF SE, Celanese Corporation, Dow Inc., Evonik Industries AG, Exxon Mobil Corporation, LyondellBasell Industries N.V., Mitsubishi Chemical Holdings Corporation, Saudi Basic Industries Corporation (SABIC), and Compagnie de Saint-Gobain S.A. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
Key Benefits For Stakeholders